Results 51 to 60 of about 214,676 (297)

Sulfadiazine induced Stevens Johnson syndrome in toxoplasmosis patient: a case report [PDF]

open access: yes, 2020
Stevens johnson syndrome is an acute, self-limited disease, presenting as severe mucosal erosions with widespread erythematous, cutaneous macules or atypical targets. Even though sulfadiazine has been mainly associated with haematological-related adverse
Kurian, Rani M.   +4 more
core   +2 more sources

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures

open access: yesAdvances in Therapy, 2017
IntroductionStevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are two of the most severe dermatologic conditions occurring in the inpatient setting. There is a lack of consensus regarding appropriate management of SJS and TEN.PurposeThe
J. Schneider, Philip R. Cohen
semanticscholar   +1 more source

Stevens‐Johnson Syndrome due to COVID‐19 vaccination

open access: yesClinical Case Reports, 2021
As public COVID‐19 vaccination programs are being implemented, it is possible that more rare and serious adverse effects such as Stevens‐Johnson syndrome (SJS) and toxic epidermal necrosis (TEN) may occur.
P. Mansouri   +3 more
semanticscholar   +1 more source

Lamotrigine-induced Stevens-Johnson syndrome in a 25 year old lady [PDF]

open access: yes, 2016
Stevens-Johnson syndrome (SJS) is an immune-complex mediated hypersensitivity reaction and has been linked as an adverse side effect to many drugs. This case is about a 25 year old woman who had lamotrigine-induced Stevens-Johnson syndrome which is known
Jadhav, Rupali B.   +2 more
core   +2 more sources

Systemic immunomodulating therapies for epidermal necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis): A systematic review and meta-analysis. [PDF]

open access: yesJ Dtsch Dermatol Ges
Summary Background and Objectives Epidermal necrolysis is a rare but severe cutaneous reaction with high mortality. Limited evidence exists regarding the efficacy of systemic immunomodulatory therapies (SITs). Our systematic review aimed to compare SITs with supportive care or one another.
Heuer R   +3 more
europepmc   +2 more sources

Successful Treatment of a Paroxysmal Kinesigenic Dyskinesia Patient with Carbamazepine-Induced Stevens-Johnson Syndrome Using Oxcarbazepine Monotherapy: A Case Report

open access: yesCase Reports in Neurology, 2021
Paroxysmal kinesigenic dyskinesia (PKD) is a rare condition characterized by abnormal involuntary movements that are precipitated by a sudden movement. PKD is often misdiagnosed with psychogenic movement disorders.
Hung T. Tran   +2 more
doaj   +1 more source

Febuxostat-induced acute liver injury [PDF]

open access: yes, 2016
Febuxostat is a unique xanthine oxidase inhibitor that was approved for the prevention of gout in the United States in 2009. Unlike allopurinol, febuxostat is not a nucleoside analogue and has a higher specificity for xanthine oxidase. Although this drug
Matt Bohm   +3 more
core   +2 more sources

Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis [PDF]

open access: yes, 2016
Steven-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare and sometimes life-threatening hypersensitivity mucocutaneous disease triggered mostly by medication and infections Major involving tissues are the mucous membranes of oral ...
���������
core   +1 more source

Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—ABCD-10

open access: yesJAMA dermatology, 2019
Importance Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a spectrum of severe mucocutaneous drug reaction associated with significant morbidity and mortality.
M. Noe   +25 more
semanticscholar   +1 more source

Stevens-Johnson syndrome induced by combined treatment: carbamazepine and cranial radiation therapy. A case of EMDART?

open access: yesPrzegląd Dermatologiczny, 2017
Introduction . In 1988, Delattre et al. described the first case of erythema multiforme associated with phenytoin and cranial radiation therapy. In 2004, Ahmed et al.
Anna Waśkiel   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy